Interleukin 24

Interleukin 24 (IL-24) is a cytokine that belongs to the interleukin family, which plays a crucial role in the immune system. It is part of the larger IL-10 cytokine family and is known for its ability to induce apoptosis in various cancer cells while sparing normal cells.
Structure and Function[edit]
IL-24 is a protein encoded by the IL24 gene in humans. It is characterized by its unique ability to selectively target cancer cells, making it a potential therapeutic agent in oncology. The cytokine functions by binding to specific receptors on the surface of target cells, initiating a cascade of intracellular signals that lead to cell death.
Mechanism of Action[edit]
The mechanism by which IL-24 induces apoptosis involves the activation of the JAK-STAT signaling pathway, which is crucial for transmitting information from extracellular chemical signals to the cell nucleus, resulting in gene expression changes. IL-24 also interacts with the endoplasmic reticulum stress pathways, further promoting apoptosis in cancer cells.
Clinical Implications[edit]
IL-24 has been studied for its potential use in gene therapy for cancer treatment. Its ability to selectively induce apoptosis in cancer cells without affecting normal cells makes it an attractive candidate for therapeutic development. Clinical trials are ongoing to evaluate the efficacy and safety of IL-24-based therapies in various types of cancer.
Related Cytokines[edit]
IL-24 is closely related to other cytokines in the IL-10 family, such as IL-19, IL-20, and IL-22. These cytokines share structural similarities and often have overlapping functions in immune regulation and inflammation.
Research and Development[edit]
Ongoing research is focused on understanding the detailed molecular mechanisms of IL-24 and its interactions with other cellular pathways. Scientists are also exploring the potential of IL-24 in combination with other cancer therapies to enhance its efficacy and overcome resistance.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian